Page last updated: 2024-10-30

memantine and Chagas Disease

memantine has been researched along with Chagas Disease in 1 studies

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research Excerpts

ExcerptRelevanceReference
"Memantine is a glutamate receptor antagonist in the central nervous system of mammals that has been used for the treatment of Alzheimer's disease."1.51The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi. ( Damasceno, FS; Marinho, CRF; Pral, EMF; Rapado, LN; Rocha, SC; Santos Souza, HF; Silber, AM, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Santos Souza, HF1
Rocha, SC1
Damasceno, FS1
Rapado, LN1
Pral, EMF1
Marinho, CRF1
Silber, AM1

Other Studies

1 other study available for memantine and Chagas Disease

ArticleYear
The effect of memantine, an antagonist of the NMDA glutamate receptor, in in vitro and in vivo infections by Trypanosoma cruzi.
    PLoS neglected tropical diseases, 2019, Volume: 13, Issue:9

    Topics: Animals; Calcium; Chagas Disease; Female; Heart; Lipopolysaccharides; Macrophages; Memantine; Mice;

2019